{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:40:34Z","timestamp":1787848834605,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["MUMS 971409"],"award-info":[{"award-number":["MUMS 971409"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005013","name":"Academic Center for Education, Culture and Research","doi-asserted-by":"publisher","award":["ACECR 3089-20"],"award-info":[{"award-number":["ACECR 3089-20"]}],"id":[{"id":"10.13039\/501100005013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12010-022-04259-y","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T11:09:01Z","timestamp":1668769741000},"page":"1862-1876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of a Novel HTLV-1 Protease: Human Fc\u03b31 Recombinant Fusion Molecule in the CHO Eukaryotic Expression System"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9050-9016","authenticated-orcid":false,"given":"Sanaz","family":"Ahmadi Ghezeldasht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastoureh","family":"Momen Heravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4254-7314","authenticated-orcid":false,"given":"Narges","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1061-5864","authenticated-orcid":false,"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Aliakbar","family":"Shamsian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8408-4664","authenticated-orcid":false,"given":"Arman","family":"Mosavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-5992","authenticated-orcid":false,"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"issue":"3","key":"4259_CR1","first-page":"179","volume":"16","author":"SA Ghezeldasht","year":"2013","unstructured":"Ghezeldasht, S. A., Shirdel, A., Assarehzadegan, M. A., Hassannia, T., Rahimi, H., Miri, R., & Rezaee, S. R. (2013). Human T lymphotropic virus type I (HTLV-I) oncogenesis: Molecular aspects of virus and host interactions in pathogenesis of adult T cell leukemia\/lymphoma (ATL). Iranian Journal of Basic Medical Sciences, 16(3), 179.","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"2","key":"4259_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/v8020031","volume":"8","author":"JL Martin","year":"2016","unstructured":"Martin, J. L., Maldonado, J. O., Mueller, J. D., Zhang, W., & Mansky, L. M. (2016). Molecular studies of HTLV-1 replication: An update. Viruses, 8(2), 31.","journal-title":"Viruses"},{"issue":"5","key":"4259_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/pathogens9050342","volume":"9","author":"F Marino-Merlo","year":"2020","unstructured":"Marino-Merlo, F., Balestrieri, E., Matteucci, C., Mastino, A., Grelli, S., & Macchi, B. (2020). Antiretroviral therapy in HTLV-1 infection: An updated overview. Pathogens, 9(5), 342.","journal-title":"Pathogens"},{"issue":"3","key":"4259_CR4","first-page":"264","volume":"24","author":"R Boostani","year":"2021","unstructured":"Boostani, R., Lotfinejad, N., Zemorshidi, F., Vahidi, Z., Rezaee, S. A., Farid, R., & Rafatpanah, H. (2021). Planning and management to control and eliminate HTLV-1 infection in Iran. Iranian Journal of Basic Medical Sciences, 24(3), 264.","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"10133","key":"4259_CR5","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/S0140-6736(18)30974-7","volume":"391","author":"F Martin","year":"2018","unstructured":"Martin, F., Tagaya, Y., & Gallo, R. (2018). Time to eradicate HTLV-1: An open letter to WHO. The Lancet, 391(10133), 1893\u20131894.","journal-title":"The Lancet"},{"issue":"2","key":"4259_CR6","first-page":"159","volume":"9","author":"P Boross","year":"2009","unstructured":"Boross, P., Bagossi, P., Weber, I. T., & Tozser, J. (2009). Drug targets in human T-lymphotropic virus type 1 (HTLV-1) infection. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders), 9(2), 159\u2013171.","journal-title":"Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders)"},{"issue":"2","key":"4259_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000331995","volume":"55","author":"S Sierra","year":"2012","unstructured":"Sierra, S., & Walter, H. (2012). Targets for inhibition of HIV replication: Entry, enzyme action, release and maturation. Intervirology, 55(2), 84\u201397. https:\/\/doi.org\/10.1159\/000331995","journal-title":"Intervirology"},{"issue":"7","key":"4259_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1099\/vir.0.82704-0","volume":"88","author":"T Sperka","year":"2007","unstructured":"Sperka, T., Miklossy, G., Tie, Y., Bagossi, P., Zahuczky, G., Boross, P., Matuz, K., Harrison, R. W., Weber, I. T., & T\u00f6zs\u00e9r, J. (2007). Bovine leukemia virus protease: Comparison with human T-lymphotropic virus and human immunodeficiency virus proteases. Journal of General Virology, 88(7), 2052\u20132063.","journal-title":"Journal of General Virology"},{"issue":"1","key":"4259_CR9","first-page":"19","volume":"5","author":"M Kheirabadi","year":"2016","unstructured":"Kheirabadi, M., Maleki, J., Soufian, S., & Hosseini, S. (2016). Design of new potent HTLV-1 protease inhibitors: In silico study. Molecular Biology Research Communications, 5(1), 19.","journal-title":"Molecular Biology Research Communications"},{"issue":"8","key":"4259_CR10","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.bmcl.2011.02.066","volume":"21","author":"J-T Nguyen","year":"2011","unstructured":"Nguyen, J.-T., Kato, K., Hidaka, K., Kumada, H.-O., Kimura, T., & Kiso, Y. (2011). Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles. Bioorganic and medicinal chemistry letters, 21(8), 2425\u20132429.","journal-title":"Bioorganic and medicinal chemistry letters"},{"issue":"6","key":"4259_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.sbi.2006.10.010","volume":"16","author":"JR Mesters","year":"2006","unstructured":"Mesters, J. R., Tan, J., & Hilgenfeld, R. (2006). Viral enzymes. Current Opinion in Structural Biology, 16(6), 776\u2013786.","journal-title":"Current Opinion in Structural Biology"},{"issue":"13","key":"4259_CR12","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1073\/pnas.85.13.4686","volume":"85","author":"NE Kohl","year":"1988","unstructured":"Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., & Sigal, I. S. (1988). Active human immunodeficiency virus protease is required for viral infectivity. Proceedings of the National Academy of Sciences, 85(13), 4686. https:\/\/doi.org\/10.1073\/pnas.85.13.4686","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"Suppl 1","key":"4259_CR13","first-page":"S28","volume":"10","author":"BA Larder","year":"1995","unstructured":"Larder, B. A. (1995). Viral resistance and the selection of anti-retroviral combinations. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10(Suppl 1), S28-33.","journal-title":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology"},{"issue":"1","key":"4259_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-020-01457-0","volume":"17","author":"M Mahdi","year":"2020","unstructured":"Mahdi, M., M\u00f3ty\u00e1n, J. A., Szojka, Z. I., Golda, M., Miczi, M., & T\u0151zs\u00e9r, J. (2020). Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2\u2019s main protease. Virology Journal, 17(1), 1\u20138.","journal-title":"Virology Journal"},{"issue":"5","key":"4259_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3109\/10799893.2014.898659","volume":"34","author":"C Selvaraj","year":"2014","unstructured":"Selvaraj, C., Singh, P., & Singh, S. K. (2014). Molecular modeling studies and comparative analysis on structurally similar HTLV and HIV protease using HIV-PR inhibitors. Journal of Receptors and Signal Transduction, 34(5), 361\u2013371. https:\/\/doi.org\/10.3109\/10799893.2014.898659","journal-title":"Journal of Receptors and Signal Transduction"},{"issue":"17","key":"4259_CR16","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul, S. F., Madden, T. L., Sch\u00e4ffer, A. A., Zhang, J., Zhang, Z., Miller, W., & Lipman, D. J. (1997). Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Research, 25(17), 3389\u20133402. https:\/\/doi.org\/10.1093\/nar\/25.17.3389","journal-title":"Nucleic Acids Research"},{"issue":"12","key":"4259_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/jmr.2395","volume":"27","author":"C Selvaraj","year":"2014","unstructured":"Selvaraj, C., Singh, P., & Singh, S. K. (2014). Molecular insights on analogs of HIV PR inhibitors toward HTLV-1 PR through QM\/MM interactions and molecular dynamics studies: Comparative structure analysis of wild and mutant HTLV-1 PR. Journal of Molecular Recognition, 27(12), 696\u2013706.","journal-title":"Journal of Molecular Recognition"},{"issue":"6","key":"4259_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10930-013-9502-5","volume":"32","author":"GJ Gopal","year":"2013","unstructured":"Gopal, G. J., & Kumar, A. (2013). Strategies for the production of recombinant protein in Escherichia coli. The Protein Journal, 32(6), 419\u2013425.","journal-title":"The Protein Journal"},{"issue":"45","key":"4259_CR19","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1016\/j.vaccine.2021.09.077","volume":"39","author":"DG Alleva","year":"2021","unstructured":"Alleva, D. G., Delpero, A. R., Scully, M. M., Murikipudi, S., Ragupathy, R., Greaves, E. K., Sathiyaseelan, T., Haworth, J. R., Shah, N. J., Rao, V., Nagre, S., Lancaster, T. M., Webb, S. S., Jasa, A. I., Ronca, S. E., Green, F. M., Elyard, H. A., Yee, J., Klein, J., \u2026 Zion, T. C. (2021). Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine, 39(45), 6601\u20136613. https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.077","journal-title":"Vaccine"},{"issue":"3","key":"4259_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4314\/tjpr.v16i3.29","volume":"16","author":"A Mahmuda","year":"2017","unstructured":"Mahmuda, A., Bande, F., Al-Zihiry, K. J. K., Abdulhaleem, N., Abd Majid, R., Hamat, R. A., Abdullah, W. O., & Unyah, Z. (2017). Monoclonal antibodies: A review of therapeutic applications and future prospects. Tropical Journal of Pharmaceutical Research, 16(3), 713\u2013722.","journal-title":"Tropical Journal of Pharmaceutical Research"},{"issue":"3","key":"4259_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/07388551.2016.1163323","volume":"37","author":"S Soleimanpour","year":"2017","unstructured":"Soleimanpour, S., Hassannia, T., Motiee, M., Amini, A. A., & Rezaee, S. (2017). Fc\u03b31 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: Immunological, biochemical and therapeutic properties. Critical Reviews in Biotechnology, 37(3), 371\u2013392.","journal-title":"Critical Reviews in Biotechnology"},{"issue":"11","key":"4259_CR22","doi-asserted-by":"publisher","first-page":"e0006913","DOI":"10.1371\/journal.pntd.0006913","volume":"12","author":"C Rosadas","year":"2018","unstructured":"Rosadas, C., Malik, B., Taylor, G. P., & Puccioni-Sohler, M. (2018). Estimation of HTLV-1 vertical transmission cases in Brazil per annum. PLoS Neglected Tropical Diseases, 12(11), e0006913. https:\/\/doi.org\/10.1371\/journal.pntd.0006913","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"24","key":"4259_CR23","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1093\/nar\/25.24.4876","volume":"25","author":"JD Thompson","year":"1997","unstructured":"Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F., & Higgins, D. G. (1997). The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research, 25(24), 4876\u20134882. https:\/\/doi.org\/10.1093\/nar\/25.24.4876","journal-title":"Nucleic Acids Research"},{"issue":"Suppl 9","key":"4259_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/prot.22570","volume":"77 Suppl 9","author":"E Krieger","year":"2009","unstructured":"Krieger, E., Joo, K., Lee, J., Lee, J., Raman, S., Thompson, J., Tyka, M., Baker, D., & Karplus, K. (2009). Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins, 77 Suppl 9(Suppl 9), 114\u2013122. https:\/\/doi.org\/10.1002\/prot.22570","journal-title":"Proteins"},{"issue":"10","key":"4259_CR25","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/emmm.201201379","volume":"4","author":"DM Czajkowsky","year":"2012","unstructured":"Czajkowsky, D. M., Hu, J., Shao, Z., & Pleass, R. J. (2012). Fc-fusion proteins: New developments and future perspectives. EMBO Molecular Medicine, 4(10), 1015\u20131028.","journal-title":"EMBO Molecular Medicine"},{"issue":"1","key":"4259_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0022-1759(82)90376-3","volume":"51","author":"JJ Langone","year":"1982","unstructured":"Langone, J. J. (1982). Use of labeled protein A in quantitative immunochemical analysis of antigens and antibodies. Journal of Immunological Methods, 51(1), 3\u201322.","journal-title":"Journal of Immunological Methods"},{"issue":"9","key":"4259_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri2155","volume":"7","author":"DC Roopenian","year":"2007","unstructured":"Roopenian, D. C., & Akilesh, S. (2007). FcRn: The neonatal Fc receptor comes of age. Nature Reviews Immunology, 7(9), 715\u2013725.","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"4259_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.20.100301.064828","volume":"20","author":"P Guermonprez","year":"2002","unstructured":"Guermonprez, P., Valladeau, J., Zitvogel, L., Th\u00e9ry, C., & Amigorena, S. (2002). Antigen presentation and T cell stimulation by dendritic cells. Annual Review of Immunology, 20(1), 621\u2013667.","journal-title":"Annual Review of Immunology"},{"issue":"1","key":"4259_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4049\/jimmunol.1100070","volume":"187","author":"C-WS Kuo","year":"2011","unstructured":"Kuo, C.-W.S., Mirsaliotis, A., & Brighty, D. W. (2011). Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralise viral infectivity at multiple steps of the entry process. The Journal of Immunology, 187(1), 361\u2013371.","journal-title":"The Journal of Immunology"},{"issue":"1","key":"4259_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.tibtech.2014.11.001","volume":"33","author":"D Levin","year":"2015","unstructured":"Levin, D., Golding, B., Strome, S. E., & Sauna, Z. E. (2015). Fc fusion as a platform technology: Potential for modulating immunogenicity. Trends in Biotechnology, 33(1), 27\u201334.","journal-title":"Trends in Biotechnology"},{"issue":"10249","key":"4259_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","volume":"396","author":"F-C Zhu","year":"2020","unstructured":"Zhu, F.-C., Guan, X.-H., Li, Y.-H., Huang, J.-Y., Jiang, T., Hou, L.-H., Li, J.-X., Yang, B.-F., Wang, L., & Wang, W.-J. (2020). Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: A randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet, 396(10249), 479\u2013488.","journal-title":"The Lancet"},{"issue":"24","key":"4259_CR32","doi-asserted-by":"publisher","first-page":"10467","DOI":"10.1007\/s00253-015-6952-z","volume":"99","author":"S Soleimanpour","year":"2015","unstructured":"Soleimanpour, S., Farsiani, H., Mosavat, A., Ghazvini, K., Eydgahi, M. R. A., Sankian, M., Sadeghian, H., Meshkat, Z., & Rezaee, S. A. (2015). APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice. Applied Microbiology and Biotechnology, 99(24), 10467\u201310480.","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"5","key":"4259_CR33","doi-asserted-by":"publisher","first-page":"586","DOI":"10.22038\/ijbms.2022.64787.14266","volume":"25","author":"MM Akbarin","year":"2022","unstructured":"Akbarin, M. M., Rafatpanah, H., Soleimanpour, S., Amini, A. A., Arian, A., Mosavat, A., & Rezaee, S. A. (2022). TAX and HBZ: hFc \u0194 1 proteins as targets for passive immunotherapy. Iranian Journal of Basic Medical Sciences, 25(5), 586\u2013596. https:\/\/doi.org\/10.22038\/ijbms.2022.64787.14266","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"4259_CR34","doi-asserted-by":"publisher","unstructured":"Shafifar, M., Mozhgani, S. H., Pashabayg, KR., Mosavat, A., Karbalaei, M., Norouzi, M., Rezaee, S. A. (2022). Selective APC-targeting of a novel Fc-fusion multi-immunodominant recombinant protein ((t)Tax-(t)Env:mFc\u03b32a) for HTLV-1 vaccine development. Life Science, 120920. https:\/\/doi.org\/10.1016\/j.lfs.2022.120920","DOI":"10.1016\/j.lfs.2022.120920"},{"issue":"24","key":"4259_CR35","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1007\/s00216-020-02796-1","volume":"412","author":"W Esser-Skala","year":"2020","unstructured":"Esser-Skala, W., Segl, M., Wohlschlager, T., Reisinger, V., Holzmann, J., & Huber, C. G. (2020). Exploring sample preparation and data evaluation strategies for enhanced identification of host cell proteins in drug products of therapeutic antibodies and Fc-fusion proteins. Analytical and Bioanalytical Chemistry, 412(24), 6583\u20136593.","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"1","key":"4259_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-020-00243-x","volume":"5","author":"R Bos","year":"2020","unstructured":"Bos, R., Rutten, L., van der Lubbe, J. E., Bakkers, M. J., Hardenberg, G., Wegmann, F., Zuijdgeest, D., de Wilde, A. H., Koornneef, A., & Verwilligen, A. (2020). Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilised SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. npj Vaccines, 5(1), 1\u201311.","journal-title":"npj Vaccines"},{"issue":"10267","key":"4259_CR37","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","volume":"396","author":"MN Ramasamy","year":"2020","unstructured":"Ramasamy, M. N., Minassian, A. M., Ewer, K. J., Flaxman, A. L., Folegatti, P. M., Owens, D. R., Voysey, M., Aley, P. K., Angus, B., & Babbage, G. (2020). Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): A single-blind, randomised, controlled, phase 2\/3 trial. The Lancet, 396(10267), 1979\u20131993.","journal-title":"The Lancet"},{"issue":"13","key":"4259_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.15585\/mmwr.mm7013e3","volume":"70","author":"MG Thompson","year":"2021","unstructured":"Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H. L., Yoon, S. K., Meece, J., Olsho, L. E., Caban-Martinez, A. J., Fowlkes, A., & Lutrick, K. (2021). Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers\u2014Eight US locations, December 2020\u2013March 2021. Morbidity and Mortality Weekly Report, 70(13), 495.","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"2","key":"4259_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40475-020-00201-6","volume":"7","author":"W-H Chen","year":"2020","unstructured":"Chen, W.-H., Strych, U., Hotez, P. J., & Bottazzi, M. E. (2020). The SARS-CoV-2 vaccine pipeline: An overview. Current tropical medicine reports, 7(2), 61\u201364.","journal-title":"Current tropical medicine reports"},{"issue":"21","key":"4259_CR40","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1056\/NEJMp2005630","volume":"382","author":"N Lurie","year":"2020","unstructured":"Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020). Developing COVID-19 vaccines at pandemic speed. New England Journal of Medicine, 382(21), 1969\u20131973.","journal-title":"New England Journal of Medicine"},{"key":"4259_CR41","doi-asserted-by":"crossref","unstructured":"Konduru, K., Shurtleff, A., Bavari, S., Kaplan, G. (2013). Evaluation of ebolavirus glycoprotein Fc fusion protein as a subunit vaccine (P4417). Am Assoc Immnol,","DOI":"10.4049\/jimmunol.190.Supp.205.18"},{"issue":"5","key":"4259_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1189\/jlb.1109767","volume":"87","author":"MT Silva","year":"2010","unstructured":"Silva, M. T. (2010). Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. Journal of Leukocyte Biology, 87(5), 805\u2013813.","journal-title":"Journal of Leukocyte Biology"},{"issue":"6","key":"4259_CR43","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1128\/JVI.01241-10","volume":"85","author":"S Loureiro","year":"2011","unstructured":"Loureiro, S., Ren, J., Phapugrangkul, P., Colaco, C. A., Bailey, C. R., Shelton, H., Molesti, E., Temperton, N. J., Barclay, W. S., & Jones, I. M. (2011). Adjuvant-free immunisation with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines. Journal of Virology, 85(6), 3010\u20133014.","journal-title":"Journal of Virology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04259-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-022-04259-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04259-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:20:31Z","timestamp":1744158031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-022-04259-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["4259"],"URL":"https:\/\/doi.org\/10.1007\/s12010-022-04259-y","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"8 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work does not contain any studies with human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}